Matthew Strobeck - 31 Mar 2022 Form 4 Insider Report for BIODESIX INC (BDSX)

Role
Director
Signature
/s/ Robin H. Cowie as Attorney-in-Fact for Matthew Strobeck
Issuer symbol
BDSX
Transactions as of
31 Mar 2022
Net transactions value
$0
Form type
4
Filing time
04 Apr 2022, 16:15:57 UTC
Previous filing
04 Jan 2022
Next filing
11 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BDSX Common Stock Options Exercise +20,044 +2.1% 986,927 31 Mar 2022 Direct F1
holding BDSX Common Stock 211,200 31 Mar 2022 By Birchview Fund LLC F3
holding BDSX Common Stock 19,933 31 Mar 2022 By Birchview Capital Separately Managed Account F3
holding BDSX Common Stock 3,518 31 Mar 2022 By UGMA Account F4
holding BDSX Common Stock 3,518 31 Mar 2022 By UGMA Account F4
holding BDSX Common Stock 3,518 31 Mar 2022 By UGMA Account F4
holding BDSX Common Stock 3,518 31 Mar 2022 By UGMA Account F4
holding BDSX Common Stock 40,665 31 Mar 2022 By Clajer Capital LLC F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BDSX Restricted Stock Units Options Exercise $0 -20,044 -100% $0.000000* 0 31 Mar 2022 Common Stock 20,044 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
F2 These restricted stock units vested in full on March 31, 2022 and had no expiration date.
F3 The reporting person has sole voting and dispositive power with respect to shares held by Birchview Fund, LLC and the Birchview Capital Separately Managed Account in his capacity as Managers of such entities. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F4 The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
F5 The reporting person is an affiliate of Clajer Capital LLC. The reporting person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.